Glycosylation Alters Oligomerization Status of the Human Ceacam1-Igv Domain

James H. Prestegard,Kelley Moremen,You Zhuo,Jeong-Yeh Yang

DOI: https://doi.org/10.1096/fasebj.30.1_supplement.1097.4

2016-01-01

Abstract:Human carcinoembryonic antigen‐related cell adhesion molecule 1 (CEACAM1) is a cell‐surface signaling molecule involved in cell adhesion, proliferation and immune response. It is also implicated in cancer angiogenesis, progression and metastasis. This diverse set of roles likely arises as a result of the numerous homophilic and heterophilic interactions that CEACAM1 can have with itself and other members of the CEACAM superfamily. Its N‐terminal Ig‐like variable (IgV) domain has been suggested to be a principal player in these interactions, facilitating cis and trans homo‐dimer formation, as well as complex formation with other molecules. The IgV domain crystal structure, which used E. coli expressed material that lacks glycosylation, shows a dimer interface that obscures a glycosylation site, while other studies using mutagenesis and electron microscopy suggest dimer formation may also be mediated by a non‐glycosylated surface on the opposite side of the molecule. Here, we use NMR cross correlation measurements and residual dipolar coupling measurements to examine the effect of glycosylation on CEACAM1‐IgV domain oligomerization status. Both a non‐glycosylated form expressed in E. coli and a glycosylated form expressed in HEK293 GnT1‐cells and trimmed to a single GlcNAc residue, were examined. Our findings demonstrate that IgV with a single N‐linked GlcNAc at all glycosylation sites inhibits dimer formation of any type, whereas formation of a dimer similar in structure to that found in the crystal structure occurs in solution when glycosylation is absent. Future studies will be directed at the role additional domains and more complex glycosylation may play in native dimer formation. Support or Funding Information Financial support provided by the National Institutes of Health, R01GM033225